Literature DB >> 12239101

Androgen modulation of adhesion and antiadhesion molecules in PC-3 prostate cancer cells expressing androgen receptor.

Andreas Evangelou1, Michelle Letarte, Alexander Marks, Theodore J Brown.   

Abstract

The metastatic spread of cancer cells involves a complex process of detachment via antiadhesion molecules and attachment and migration through adhesion. In the prostate, androgens are generally thought to contribute to the development and progression of prostate cancer by promoting cell proliferation and survival through poorly defined mechanisms. We have reported previously that PC-3 prostate cancer cells, which are unresponsive to androgens, show androgen-dependent detachment and ultimately apoptosis when stably transfected with a full-length human androgen receptor (AR) cDNA. We now demonstrate that treatment of these cells with 5alpha-dihydrotestosterone (DHT) for 24 or 48 h increased the expression of antiadhesion mucin MUC-1 at the cell surface as detected by flow cytometry with two independent antibodies. This increase in protein was concordant with up-regulation of MUC-1 mRNA in the AR-transfected PC-3 sublines, as determined by quantitative RT-PCR. Treatment with DHT for 48 h also down-regulated the cell surface expression of alpha2beta1-integrin but having little effect on the levels of alpha3beta1- and alpha5beta1-integrins. Androgen also decreased, in a dose-dependent manner, the adhesion of AR-transfected PC-3 cells to collagen type I, which was shown to be specifically inhibited by blocking antibody to alpha2beta1-integrin. The present data demonstrate that DHT can modulate expression of adhesion and antiadhesion molecules and suggest that this effect of androgen might contribute to prostate cancer progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12239101     DOI: 10.1210/en.2002-220156

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  The androgen receptor induces integrin α6β1 to promote prostate tumor cell survival via NF-κB and Bcl-xL Independently of PI3K signaling.

Authors:  Laura E Lamb; Jelani C Zarif; Cindy K Miranti
Journal:  Cancer Res       Date:  2011-02-10       Impact factor: 12.701

2.  Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.

Authors:  David J Degraff; Adam A Aguiar; Robert A Sikes
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

3.  Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells.

Authors:  Ming-Yi Li; Hua Deng; Jia-Ming Zhao; Dong Dai; Xiao-Yu Tan
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

4.  Genomic and proteomic analysis of the impact of mitotic quiescence on the engraftment of human CD34+ cells.

Authors:  Brahmananda Reddy Chitteti; Yunlong Liu; Edward F Srour
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

5.  Estrogen and Androgen Hormone Levels Modulate the Expression of PIWI Interacting RNA in Prostate and Breast Cancer.

Authors:  Çağrı Öner; Didem Turgut Coşan; Ertuğrul Çolak
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

Review 6.  Integrin αvβ3 in the Mediating Effects of Dihydrotestosterone and Resveratrol on Breast Cancer Cell Proliferation.

Authors:  Yih Ho; Zi-Lin Li; Ya-Jung Shih; Yi-Ru Chen; Kuan Wang; Jacqueline Whang-Peng; Hung-Yun Lin; Paul J Davis
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

7.  Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression data.

Authors:  Ivan P Gorlov; Jinyoung Byun; Olga Y Gorlova; Ana M Aparicio; Eleni Efstathiou; Christopher J Logothetis
Journal:  BMC Med Genomics       Date:  2009-08-04       Impact factor: 3.063

8.  Integrin involvement in freeze resistance of androgen-insensitive prostate cancer.

Authors:  J G Baust; D P Klossner; R G Vanbuskirk; A A Gage; V Mouraviev; T J Polascik; J M Baust
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-01-12       Impact factor: 5.554

9.  MUC-1 gene is associated with prostate cancer death: a 20-year follow-up of a population-based study in Sweden.

Authors:  O Andrén; K Fall; S-O Andersson; M A Rubin; T A Bismar; M Karlsson; J-E Johansson; L A Mucci
Journal:  Br J Cancer       Date:  2007-08-28       Impact factor: 7.640

10.  RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.

Authors:  Mark Sutherland; Andrew Gordon; Steven D Shnyder; Laurence H Patterson; Helen M Sheldrake
Journal:  Cancers (Basel)       Date:  2012-10-26       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.